[English] 日本語
Yorodumi- EMDB-48275: Native tagless Lassa virus spike complex bound to ARN-75039 at pH 8.0 -
+
Open data
-
Basic information
| Entry | ![]() | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | Native tagless Lassa virus spike complex bound to ARN-75039 at pH 8.0 | |||||||||
Map data | Raw map | |||||||||
Sample |
| |||||||||
Keywords | Spike complex / VIRAL PROTEIN | |||||||||
| Function / homology | Function and homology informationhost cell Golgi membrane / receptor-mediated endocytosis of virus by host cell / host cell endoplasmic reticulum membrane / fusion of virus membrane with host endosome membrane / viral envelope / virion attachment to host cell / host cell plasma membrane / virion membrane / metal ion binding / membrane Similarity search - Function | |||||||||
| Biological species | Lassa virus Josiah / Homo sapiens (human) | |||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 2.01 Å | |||||||||
Authors | Cohen-Dvashi H / Katz M / Diskin R | |||||||||
| Funding support | 1 items
| |||||||||
Citation | Journal: Cell Host Microbe / Year: 2025Title: pH-induced conformational changes and inhibition of the Lassa virus spike complex. Authors: Michael Katz / Hadas Cohen-Dvashi / Sarah Borni / John Ruedas / Greg Henkel / Ken McCormack / Ron Diskin / ![]() Abstract: Lassa virus (LASV) is a devastating human pathogen with no vaccines and limited therapeutics. The LASV class-I spike complex engages target cells via binding its primary host receptor, matriglycan, ...Lassa virus (LASV) is a devastating human pathogen with no vaccines and limited therapeutics. The LASV class-I spike complex engages target cells via binding its primary host receptor, matriglycan, followed by macropinocytosis and binding of its secondary receptor, lysosomal-associated membrane protein 1 (LAMP1), to trigger virus fusion. This process occurs across multiple pH-dependent steps, but the molecular events remain largely unknown. Through high-resolution structures, we study the pH-induced conformational changes of the spike preceding membrane fusion. We reveal pH-sensitive metal coordination sites that control the integrity of the spike's native state, elucidate a reorganization of the spike's transmembrane region, and provide a mechanism for dissociation from its primary receptor. Using the entry inhibitor ARN-75039, we validate our findings and establish the molecular basis for the binding and function of this investigational drug. These data define the molecular basis for the cell entry of LASV and will promote efforts in combating this virus and potentially related viral pathogens. | |||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_48275.map.gz | 89.8 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-48275-v30.xml emd-48275.xml | 24.5 KB 24.5 KB | Display Display | EMDB header |
| FSC (resolution estimation) | emd_48275_fsc.xml | 11.8 KB | Display | FSC data file |
| Images | emd_48275.png | 127.5 KB | ||
| Filedesc metadata | emd-48275.cif.gz | 7.1 KB | ||
| Others | emd_48275_additional_1.map.gz emd_48275_half_map_1.map.gz emd_48275_half_map_2.map.gz | 2.9 MB 165 MB 165 MB | ||
| Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-48275 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-48275 | HTTPS FTP |
-Validation report
| Summary document | emd_48275_validation.pdf.gz | 922.5 KB | Display | EMDB validaton report |
|---|---|---|---|---|
| Full document | emd_48275_full_validation.pdf.gz | 922.1 KB | Display | |
| Data in XML | emd_48275_validation.xml.gz | 20.3 KB | Display | |
| Data in CIF | emd_48275_validation.cif.gz | 26.4 KB | Display | |
| Arichive directory | https://ftp.pdbj.org/pub/emdb/validation_reports/EMD-48275 ftp://ftp.pdbj.org/pub/emdb/validation_reports/EMD-48275 | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 9mheMC ![]() 9mivC ![]() 9miyC ![]() 9mj1C ![]() 9mj2C ![]() 9r8uC M: atomic model generated by this map C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|
-
Map
| File | Download / File: emd_48275.map.gz / Format: CCP4 / Size: 178 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Raw map | ||||||||||||||||||||||||||||||||||||
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 0.8242 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Additional map: Local-resolution filtered map
| File | emd_48275_additional_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Local-resolution filtered map | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: Half map B
| File | emd_48275_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Half map B | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: Half map A
| File | emd_48275_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Half map A | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : Spike complex of Lassa virus bound by 12.1F and ARN-75039
| Entire | Name: Spike complex of Lassa virus bound by 12.1F and ARN-75039 |
|---|---|
| Components |
|
-Supramolecule #1: Spike complex of Lassa virus bound by 12.1F and ARN-75039
| Supramolecule | Name: Spike complex of Lassa virus bound by 12.1F and ARN-75039 type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1-#4 |
|---|---|
| Source (natural) | Organism: Lassa virus Josiah |
-Macromolecule #1: Glycoprotein G2
| Macromolecule | Name: Glycoprotein G2 / type: protein_or_peptide / ID: 1 / Number of copies: 3 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Lassa virus Josiah |
| Molecular weight | Theoretical: 26.828064 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: GTFTWTLSDS EGKDTPGGYC LTRWMLIEAE LKCFGNTAVA KCNEKHDEEF CDMLRLFDFN KQAIQRLKAE AQMSIQLINK AVNALINDQ LIMKNHLRDI MGIPYCNYSK YWYLNHTTTG RTSLPKCWLV SNGSYLNETH FSDDIEQQAD NMITEMLQKE Y MERQGKTP ...String: GTFTWTLSDS EGKDTPGGYC LTRWMLIEAE LKCFGNTAVA KCNEKHDEEF CDMLRLFDFN KQAIQRLKAE AQMSIQLINK AVNALINDQ LIMKNHLRDI MGIPYCNYSK YWYLNHTTTG RTSLPKCWLV SNGSYLNETH FSDDIEQQAD NMITEMLQKE Y MERQGKTP LGLVDLFVFS TSFYLISIFL HLVKIPTHRH IVGKSCPKPH RLNHMGICSC GLYKQPGVPV KWKR UniProtKB: Pre-glycoprotein polyprotein GP complex |
-Macromolecule #2: Glycoprotein G1
| Macromolecule | Name: Glycoprotein G1 / type: protein_or_peptide / ID: 2 / Number of copies: 3 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Lassa virus Josiah |
| Molecular weight | Theoretical: 29.064402 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: MGQIVTFFQE VPHVIEEVMN IVLIALSVLA VLKGLYNFAT CGLVGLVTFL LLCGRSCTTS LYKGVYELQT LELNMETLNM TMPLSCTKN NSHHYIMVGN ETGLELTLTN TSIINHKFCN LSDAHKKNLY DHALMSIIST FHLSIPNFNQ YEAMSCDFNG G KISVQYNL ...String: MGQIVTFFQE VPHVIEEVMN IVLIALSVLA VLKGLYNFAT CGLVGLVTFL LLCGRSCTTS LYKGVYELQT LELNMETLNM TMPLSCTKN NSHHYIMVGN ETGLELTLTN TSIINHKFCN LSDAHKKNLY DHALMSIIST FHLSIPNFNQ YEAMSCDFNG G KISVQYNL SHSYAGDAAN HCGTVANGVL QTFMRMAWGG SYIALDSGRG NWDCIMTSYQ YLIIQNTTWE DHCQFSRPSP IG YLGLLSQ RTRDIYISRR LL UniProtKB: Pre-glycoprotein polyprotein GP complex |
-Macromolecule #3: 12.1F Heavy chain
| Macromolecule | Name: 12.1F Heavy chain / type: protein_or_peptide / ID: 3 / Number of copies: 3 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 26.79373 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: QVQLQESGAG LLKPSETLSL SCTVDGESFN GFFWTWIRQP PGKGLEWIGE INHLASTGYN PSLKSRVTIS VDTSKNQFSL KLTSVTAAD TAVYYCARGY SYGFAWPNYH YLDVWGKGTT VTVSSASTKG PSVFPLAPSS KSTSGGTAAL GCLVKDYFPE P VTVSWNSG ...String: QVQLQESGAG LLKPSETLSL SCTVDGESFN GFFWTWIRQP PGKGLEWIGE INHLASTGYN PSLKSRVTIS VDTSKNQFSL KLTSVTAAD TAVYYCARGY SYGFAWPNYH YLDVWGKGTT VTVSSASTKG PSVFPLAPSS KSTSGGTAAL GCLVKDYFPE P VTVSWNSG ALTSGVHTFP AVLQSSGLYS LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKRVEPKSCD KTHGGDYKDD DD KGTENLY FQ |
-Macromolecule #4: 12.1F Light chain
| Macromolecule | Name: 12.1F Light chain / type: protein_or_peptide / ID: 4 / Number of copies: 3 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 23.492086 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: EIVLTQSPAT LSLSPGERAT LSCRASQSVS SYLAWYQHKP GQAPRLLIYG ASKRATGIPS RFSGSGSGTD FSLTISSLEP EDFAVYYCQ HRSDWRTTFG QGTRLEIKRT VAAPSVFIFP PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS Q ESVTEQDS ...String: EIVLTQSPAT LSLSPGERAT LSCRASQSVS SYLAWYQHKP GQAPRLLIYG ASKRATGIPS RFSGSGSGTD FSLTISSLEP EDFAVYYCQ HRSDWRTTFG QGTRLEIKRT VAAPSVFIFP PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS Q ESVTEQDS KDSTYSLSST LTLSKADYEK HKVYACEVTH QGLSSPVTKS FNRGEC |
-Macromolecule #13: 2-acetamido-2-deoxy-beta-D-glucopyranose
| Macromolecule | Name: 2-acetamido-2-deoxy-beta-D-glucopyranose / type: ligand / ID: 13 / Number of copies: 10 / Formula: NAG |
|---|---|
| Molecular weight | Theoretical: 221.208 Da |
| Chemical component information | ![]() ChemComp-NAG: |
-Macromolecule #14: UNKNOWN LIGAND
| Macromolecule | Name: UNKNOWN LIGAND / type: ligand / ID: 14 / Number of copies: 2 / Formula: UNX |
|---|---|
| Molecular weight | Theoretical: 54.938 Da |
| Chemical component information | ![]()
ChemComp-UNL: |
-Macromolecule #15: (4S)-3-(4-tert-butoxyphenyl)-7-methyl-6-{4-[(propan-2-yl)oxy]phen...
| Macromolecule | Name: (4S)-3-(4-tert-butoxyphenyl)-7-methyl-6-{4-[(propan-2-yl)oxy]phenyl}imidazo[1,2-a]pyridine type: ligand / ID: 15 / Number of copies: 1 / Formula: A1BK9 |
|---|---|
| Molecular weight | Theoretical: 414.539 Da |
-Macromolecule #16: water
| Macromolecule | Name: water / type: ligand / ID: 16 / Number of copies: 983 / Formula: HOH |
|---|---|
| Molecular weight | Theoretical: 18.015 Da |
| Chemical component information | ![]() ChemComp-HOH: |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Buffer | pH: 8 |
|---|---|
| Vitrification | Cryogen name: ETHANE |
-
Electron microscopy
| Microscope | TFS KRIOS |
|---|---|
| Image recording | Film or detector model: GATAN K3 (6k x 4k) / Average electron dose: 38.0 e/Å2 |
| Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 1.8 µm / Nominal defocus min: 0.6 µm |
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
Movie
Controller
About Yorodumi



Keywords
Lassa virus Josiah
Homo sapiens (human)
Authors
Citation














Z (Sec.)
Y (Row.)
X (Col.)















































Processing
FIELD EMISSION GUN

